Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Cervical dystonia: current rehabilitation strategies and methods

Full Text:


Idiopathic cervical dystonia (CD) is a movement disorder that is characterized by sustained or intermittent muscle contractions causing often repetitive movements, fixed postures, or both. This is the most common form of focal dystonia. The lack of highly effective rehabilitation in CD can substantially increase the number of disabled people and/or lead to a significant decrease in the working capacity of young patients. Despite the high social significance of the problem, there are currently insufficient studies of the use of medical and physical rehabilitation methods for CD. Taking into account the complexity, multicomponent pattern, and clinical diversity of CD manifestations, these patients require multidisciplinary treatment and rehabilitation approaches to achieve maximum results. This review discusses rehabilitation strategies and methods in CD, which are based on the modern understanding of the etiology and pathogenesis of the disease. As a supplement to botulinum toxin therapy, a multimodal physiotherapy program, kinesio taping, and special and general strengthening physical exercises are considered, which can assist in correcting the posture, reducing the severity of pain in patients with CD, improving daily activity, and increasing the intervals between botulinum toxin injections and lowering the dose of the drug administered.

About the Authors

A. S. Istomina
Institute of Experimental Medicine
Russian Federation

9, Academician Pavlov St., Petersburg 197376

I. V. Miliukhina
Institute of Experimental Medicine; Acad. I.P. Pavlov First Saint Petersburg State Medical University
Russian Federation

Irina V. Miliukhina

9, Academician Pavlov St., Petersburg 197376, 

6-8, Lev Tolstoy St., Saint Petersburg 197022

M. D. Didur
N.P. Bekhtereva Institute of Human Brain, Russian Academy of Sciences
Russian Federation

9, Academician Pavlov St., Petersburg 197376


1. Defazio G, Jankovic J, Giel JL, et al. Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (N Y). 2013 Nov 4;3:tre-03-193-4374-2. doi: 10.7916/D80C4TGJ. eCollection 2013.

2. Warner T, Camfield L, Marsden CD, et al. A prevalence study of primary dystonia in eight European countries. J Neurol. 2000 Oct;247(10):787-92. doi: 10.1007/s004150070094

3. Jankovic J, Tsui J, Bergeron C. Prevalence of cervical dystonia and spasmodic torticollis in the United States general population. Parkinsonism Relat Disord. 2007 Oct;13(7):411- 6. doi: 10.1016/j.parkreldis.2007.02.005. Epub 2007 Apr 17.

4. Albanese A, Asmus F, Bhatia KP. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011 Jan;18(1):5- 18. doi: 10.1111/j.1468-1331.2010.03042.x

5. Scott AN, Jinnah HA, Alberto JE, et al. Clinical and Demographic Characteristics Related to Onset. Site and Spread of Cervical Dystonia. Mov Disord. 2016 Dec;31(12):1874- 82. doi: 10.1002/mds.26817. Epub 2016 Oct 18.

6. Comella C, Bhatia K. An international survey of patients with cervical dystonia. J Neurol. 2015;262(4):837-48. doi: 10.1007/s00415-014-7586-2. Epub 2015 Jan 22.

7. Camargo CH, Cattai L, Teive HA. Pain relief in cervical dystonia with botulinum toxin treatment. Toxins (Basel). 2015 Jun 23;7(6):2321-35. doi: 10.3390/toxins7062321

8. Pekmezovic T, Svetel M, Ivanovic N, et al. Quality of life in patients with focal dystonia. Clin Neurol Neurosurg. 2009 Feb;111(2):161-4. doi: 10.1016/j.clineuro.2008.09.023. Epub 2008 Nov 7.

9. Van den Dool J, Tijssen MA, Koelman JH, et al. Determinants of disability in cervical dystonia. Parkinsonism Relat Disord. 2016 Nov;32:48-53. doi: 10.1016/j.parkreldis.2016.08.014. Epub 2016 Aug 15.

10. Salouchina NI, Nodel MR, Tolmacheva VA. Non-motor disorders in patients with muscular dystonia. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2018;118(9):98-105. doi: 10.17116/jnevro201811809198 (In Russ.).

11. Orlova OR, Kostenko EV, eds. Fokal'nyye distonii: diagnostika i lecheniye s ispol'zovaniyem botulinoterapii: Uchebnoye posobiye [Focal dystonia: diagnosis and treatment using botulinum therapy]. Moscow: Medpress-inform; 2018. 112 p. (In Russ.).

12. De Pauw J, van der Velden K, Meirte J, et al. The effectiveness of physiotherapy for cervical dystonia: A systematic literature review. J Neurol. 2014 Oct;261(10):1857-65. doi: 10.1007/s00415-013-7220-8. Epub 2014 Jan 12.

13. Pelosin E, Avanzino L, Marchese R, et al. KinesioTaping Reduces Pain and Modulates Sensory Function in Patients with Focal Dystonia: A Randomized Crossover Pilot Study. Neurorehabil Neural Repair. 2013;27(8):722-31. doi: 10.1177/1545968313491010

14. Tinazzi M, Fiaschi A, Frasson E, et al. Deficits of temporal discrimination in dystonia are independent from the spatial distance between the loci of tactile stimulation. Mov Disord. 2002 Mar;17(2):333-8. doi: 10.1002/mds.10019

15. Halseth T, McChesney JW, DeBeliso M, et al. The effects of kinesio taping on proprioception at the ankle. J Sports Sci Med. 2004;3:1- 7. doi: 10.1016/j.ptsp.2013.11.006

16. Achkasov EE, Belyakova AM, Kasatkin MS, et al. Klinicheskoe rukovodstvo po kineziologicheskomu teypirovaniyu [Clinical Guide to Kinesiology Taping]. Moscow; 2017. 336 p. (In Russ.).

17. Prudente CN, Zetterberg L, Bring A, et al. Systematic review of rehabilitation in focal dystonias: classification and recommendations. Mov Disord Clin Pract. 2018 Mar 13;5(3):237- 45. doi: 10.1002/mdc3.12574. eCollection MayJun 2018.

18. Delnooz C, Horstink M, Tijssen M, et al. Paramedical treatment in primary dystonia: a systematic review. Mov Disord. 2009 Nov 15;24(15):2187-98. doi: 10.1002/mds.22608

19. El-Bahrawy M, El-Tamawy M, Shalaby N, et al. Cervical dystonia: abnormal head posture and its relation to hand function. Egypt J Neurol Psychiat Neurosurg. 2009;46(1):203-8.

20. Queiroz MA, Chien HF, Sekeff-Sallem FA, et al. Physical therapy program for cervical dystonia: a study of 20 cases. Funct Neurol. Jul-Sep 2012;27(3):187-92. doi: 10.1002/mds.870120526

21. Tassorelli C, Mancini F, Balloni L, et al. Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia. Mov Disord. 2006 Dec;21(12):2240-3. doi: 10.1002/mds.21145

22. Boyce MJ, Canning CG, Mahant N, et al. Active exercise for individuals with cervical dystonia: a pilot randomized controlled trial. Clin Rehabil. 2013 Mar;27(3):226-35. doi: 10.1177/0269215512456221. Epub 2012 Aug 17.

23. Smania N, Corato E, Tinazzi M. The Effect of Two Different Rehabilitation Treatments in Cervical Dystonia: Preliminary Results in Four Patients. Funct Neurol. Oct-Dec 2003;18(4):219-25. doi: 10.1080/09593980701884816

24. Zetterberg L, Halvorsen K, Färnstrand C. Physiotherapy in Cervical Dystonia: Six Experimental Single-Case Studies. Physiother Theory Pract. Jul-Aug 2008;24(4):275-90. doi: 10.1080/09593980701884816

25. Van den Dool J, Visser B, Koelman JH, et al. Long-Term Specialized Physical Therapy in Cervical Dystonia: Outcomes of a Randomized Controlled Trial. Arch Phys Med Rehabil. 2019 Aug;100(8):1417-25. doi: 10.1016/j.apmr.2019.01.013. Epub 2019 Feb 20.

26. Bleton JP. Spasmodic torticollis. In: Handbook of rehabilitative physiotherapy. Paris; 1994. 75 p.

27. Bradnam LV, McDonnell MN, Ridding MC. Cerebellar Intermittent ThetaBurst Stimulation and Motor Control Training in Individuals with Cervical Dystonia. Brain Sci. 2016 Nov 23;6(4):56. doi: 10.3390/brainsci6040056

28. Zalyalova ZA, Khafizova IF, Khayatova ZG. Pathophysiological bases of rehabilitation in cervical dystony. Farmateka. 2017;15:7-15 (In Russ.).

29. Simpson DM, Hallett M, Ashman EJ, et al. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86(19):1818-26. doi: 10.1212/WNL.0000000000002560

30. Evidente VG, Fernandez HH, LeDoux MS, et al. A randomized, double-blind study of repeated incobotulinumtoxin A (Xeomin(®)) in cervical dystonia. J Neural Transm (Vienna). 2013 Dec;120(12):1699-707. doi: 10.1007/s00702-013-1048-3. Epub 2013 Jun 19.

31. Evidente VG, Truong D, Jankovic J, et al. IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. J Neurol Sci. 2014 Nov 15;346(1- 2):116-20. doi: 10.1016/j.jns.2014.08.004. Epub 2014 Aug 10.

32. Sanz-Granda A, Marti MJ, Catalan MJ, et al. Analisis coste-utilidad de dos formulaciones de toxina botulinica de tipo A en el tratamiento del blefaroespasmo y la distonia cervical en Espana. Rev Neurol. 2018;67(12):465-72. doi: 10.33588/rn.6712.2018062 [Sanz-Granda A, Marti MJ, Catalan MJ, et al. Cost-utility analysis of two formulations of botulinum toxin type A in the treatment of blepharospasm and cervical dystonia in Spain. Rev Neurol. 2018;67(12):465-72. doi: 10.33588/rn.6712.2018062 (In Span.)].

33. Tilden D, Guarnieri C. Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia. Value Health. Mar-Apr 2016;19(2):145-52. doi: 10.1016/j.jval.2015.11.009. Epub 2015 Dec 29.


For citations:

Istomina A.S., Miliukhina I.V., Didur M.D. Cervical dystonia: current rehabilitation strategies and methods. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(5):98-103. (In Russ.)

Views: 950

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)